[The efficacy and safety of low-dose rituximab in treatment of primary Sjögren's syndrome with thrombocytopenia].

Zhonghua nei ke za zhi [Chinese journal of internal medicine]

Volumn 51, Issue 1, 2012, Pages 37-41

  Zhou, L ^a   Xin, Xia fei ^b   Wu, Hua xiang ^b  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; RITUXIMAB;

ADULT; ARTICLE; CASE REPORT; FEMALE; HUMAN; MIDDLE AGED; SJOEGREN SYNDROME; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ADULT; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; FEMALE; HUMANS; MIDDLE AGED; SJOGREN'S SYNDROME; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 84873334396     PISSN: 05781426     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)